Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04891146
Other study ID # AbdurrahmanYAOTRH
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 5, 2020
Est. completion date December 12, 2020

Study information

Verified date March 2021
Source Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The effects of different anesthesia methods on the immune system are variable. In this study, we investigated the effect of inhalation anesthesia and total intravenous anesthesia on the SII value in major abdominal cancer surgeries.


Description:

The study was planned prospectively, observationally, on a total of 90 patients who underwent major abdominal cancer surgery. 84 patients were evaluated. The patients were seperated in two groups as inhalation anesthesia and total intravenous anesthesia (TIVA). The demographic data of the patients, type of cancer, type of surgery performed, ASA classification, preoperative chemotherapy intake, preoperative hemogram, postoperative 2nd and 24th hour hemogram, intraoperative and postoperative blood transfusion, and duration of surgery were recorded. Platelet, neutrophil, lymphocyte and SII values were saved.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date December 12, 2020
Est. primary completion date September 15, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - major abdominal cancer surgeries Exclusion Criteria: - blood transfusion in last 72 hours - patients with infection - hematologic malignancy - patient controlled analgesia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Systemic inflammatory immmune index
Systemic Inflammatory Immune index calculated from platelet, neutrophil and lymphocyte count

Locations

Country Name City State
Turkey Dr. Abdurrahman Yurtaslan Oncology Research and Trainee Hospital Ankara Yenimahalle

Sponsors (1)

Lead Sponsor Collaborator
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. doi: 1 — View Citation

Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016 Apr;69(2):126-32. doi: 10.40 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary investigate the effect of anesthesia management on the change of preoperative systemic inflammatory immune index(SII) and postoperative 2.hour and 24.hour SII value systemic inflammatory immune index calculated by (platelet x neutrophil)/lymphocyte preoperative SII noted, postoperative 2.hour noted and postoperative 24.hour noted
See also
  Status Clinical Trial Phase
Completed NCT00377520 - A Trial for Patients With Advanced/Recurrent Endometrial Cancer Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Completed NCT02387645 - LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma N/A
Recruiting NCT04438564 - Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients N/A
Recruiting NCT05742711 - Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients N/A
Suspended NCT06253494 - Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer Phase 1/Phase 2
Recruiting NCT05273099 - Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
Completed NCT05233059 - FitEx for Endometrial Cancer Survivors N/A
Recruiting NCT02545348 - Use of the Sentinel Node Biopsy for Early Endometrial Cancer.
Recruiting NCT00726635 - The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Phase 3
Completed NCT00859768 - The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients N/A